カテゴリー： Transparency Market Research, 世界, 医療/バイオ

ペニシリンGアシラーゼの世界市場2023～2031：由来別、用途別

◆英語タイトル：Penicillin G Acylase Market (Source: E. coli, Bacillus Megaterium, and Others; Application: Production of Semisynthetic Penicillin, Production of Semisynthetic Cephalosporin, and Others.) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Transparency Market Researchが発行した調査報告書（TMR23MA136）◆商品コード：TMR23MA136
◆発行会社（リサーチ会社）：Transparency Market Research
◆発行日：2023年3月3日
◆ページ数：157
◆レポート形式：英語 / PDF
◆納品方法：Eメール（納期はお問い合わせください。）
◆調査対象地域：北米、中南米、ヨーロッパ、アジア太平洋、中東・アフリカ
◆産業分野：製薬
◆販売価格オプション（消費税別）
Single User（1名様閲覧）USD5,795 ⇒換算￥880,840見積依頼/購入/質問フォーム
Multi User（5名様閲覧）USD8,795 ⇒換算￥1,336,840見積依頼/購入/質問フォーム
Corporate License（法人閲覧）USD11,795 ⇒換算￥1,792,840見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Transparency Market Research社の本市場調査報告書によると、世界のペニシリンGアシラーゼ市場規模が、2023年の672.5百万ドルから2031年には11億ドルまでCAGR 5.6%成長すると予測されています。本書はペニシリンGアシラーゼの世界市場について多角的に調査・分析し、序論、仮定、調査方法、エグゼクティブサマリー、市場概要、新型コロナウイルス感染症分析、由来別（E.大腸菌、巨大菌、その他）分析、用途別（半合成ペニシリン生産、半合成セファロスポリン生産、その他）分析、エンドユーザー別（製薬会社、学術&研究機関、その他）分析、地域別（北米、中南米、ヨーロッパ、アジア太平洋、中東・アフリカ）分析、競争状況、主要ポイントなどの内容を掲載しています。なお、本書には、Merck KGaA (Sigma Aldrich)、Fermenta Biotech Ltd.、Biosynth、Amicogen、Creative Enzymes、Crawford Wisdom International、MuseChem Chemicalsなどの企業情報が含まれています。
・序論
・仮定
・調査方法
・エグゼクティブサマリー
・市場概要
・新型コロナウイルス感染症分析
・世界のペニシリンGアシラーゼ市場規模：由来別
- E.大腸菌の市場規模
- 巨大菌の市場規模
- その他由来の市場規模
・世界のペニシリンGアシラーゼ市場規模：用途別
- 半合成ペニシリン生産における市場規模
- 半合成セファロスポリン生産における市場規模
- その他用途における市場規模
・世界のペニシリンGアシラーゼ市場規模：エンドユーザー別
- 製薬会社における市場規模
- 学術&研究機関における市場規模
- その他エンドユーザーにおける市場規模
・世界のペニシリンGアシラーゼ市場規模：地域別
- 北米のペニシリンGアシラーゼ市場規模
- 中南米のペニシリンGアシラーゼ市場規模
- ヨーロッパのペニシリンGアシラーゼ市場規模
- アジア太平洋のペニシリンGアシラーゼ市場規模
- 中東・アフリカのペニシリンGアシラーゼ市場規模
・競争状況
・企業情報
・主要ポイント

Penicillin G Acylase Market – Scope of Report
TMR’s report on the global penicillin G acylase market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global penicillin G acylase market for the period 2017–2031, considering 2022 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global penicillin G acylase market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the penicillin G acylase market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global penicillin G acylase market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global penicillin G acylase market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global penicillin G acylase market.

The report delves into the competitive landscape of the global penicillin G acylase market. Key players operating in the global penicillin G acylase market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global penicillin G acylase market profiled in this report.

Key Questions Answered in Global Penicillin G Acylase Market Report
• What is the sales/revenue generated by penicillin G acylase across all regions during the forecast period?
• What are the opportunities in the global penicillin G acylase market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Penicillin G Acylase Market – Research Objectives and Research Approach
The comprehensive report on the global penicillin G acylase market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global penicillin G acylase market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global penicillin G acylase market.

❖ レポートの目次 ❖

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Penicillin G Acylase Market
4. Market Overview
    4.1. Introduction
        4.1.1. Segment Definition
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Penicillin G Acylase Market Analysis and Forecast, 2017–2031
        4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
    5.1. Penicillin G Acylase Preform and Immobilize form: An Overview
    5.2. Regulatory Scenario by Region/globally
    5.3. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Penicillin G Acylase Market Analysis and Forecast, By Source
    6.1. Introduction & Definition
    6.2. Key Findings / Developments
    6.3. Market Value Forecast, by Source, 2017–2031
        6.3.1. E. coli
        6.3.2. Bacillus Megaterium
        6.3.3. Others
    6.4. Market Attractiveness Analysis, By Source
7. Global Penicillin G Acylase Market Analysis and Forecast, By Application
    7.1. Introduction & Definition
    7.2. Key Findings / Developments
    7.3. Market Value Forecast, by Application, 2017–2031
        7.3.1. Production of Semisynthetic Penicillin
        7.3.2. Production of Semisynthetic Cephalosporin
        7.3.3. Others
    7.4. Market Attractiveness Analysis, By Application
8. Global Penicillin G Acylase Market Analysis and Forecast, By End-user
    8.1. Introduction & Definition
    8.2. Key Findings / Developments
    8.3. Market Value Forecast, by End-user, 2017–2031
        8.3.1. Pharmaceutical Companies
        8.3.2. Academic & Research Institutes
        8.3.3. Others
    8.4. Market Attractiveness Analysis, By End-user
9. Global Penicillin G Acylase Market Analysis and Forecast, By Region
    9.1. Key Findings
    9.2. Market Value Forecast, by Region
        9.2.1. North America
        9.2.2. Europe
        9.2.3. Asia Pacific
        9.2.4. Latin America
        9.2.5. Middle East & Africa
    9.3. Market Attractiveness Analysis, By Region
10. North America Penicillin G Acylase Market Analysis and Forecast
    10.1. Introduction
        10.1.1. Key Findings
    10.2. Market Value Forecast, by Source, 2017–2031
        10.2.1. E. coli
        10.2.2. Bacillus Megaterium
        10.2.3. Others
    10.3. Market Value Forecast, by Application, 2017–2031
        10.3.1. Production of Semisynthetic Penicillin
        10.3.2. Production of Semisynthetic Cephalosporin
        10.3.3. Others
    10.4. Market Value Forecast, by End-user, 2017–2031
        10.4.1. Pharmaceutical Companies
        10.4.2. Academic & Research Institutes
        10.4.3. Others
    10.5. Market Value Forecast, by Country, 2017–2031
        10.5.1. U.S.
        10.5.2. Canada
    10.6. Market Attractiveness Analysis
        10.6.1. By Source
        10.6.2. By Application
        10.6.3. By End-user
        10.6.4. By Country
11. Europe Penicillin G Acylase Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast, by Source, 2017–2031
        11.2.1. E. coli
        11.2.2. Bacillus Megaterium
        11.2.3. Others
    11.3. Market Value Forecast, by Application, 2017–2031
        11.3.1. Production of Semisynthetic Penicillin
        11.3.2. Production of Semisynthetic Cephalosporin
        11.3.3. Others
    11.4. Market Value Forecast, by End-user, 2017–2031
        11.4.1. Pharmaceutical Companies
        11.4.2. Academic & Research Institutes
        11.4.3. Others
    11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        11.5.1. Germany
        11.5.2. U.K
        11.5.3. France
        11.5.4. Italy
        11.5.5. Spain
        11.5.6. Rest of Europe
    11.6. Market Attractiveness Analysis
        11.6.1. By Source
        11.6.2. By Application
        11.6.3. By End-user
        11.6.4. By Country/Sub-region
12. Asia Pacific Penicillin G Acylase Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast, by Source, 2017–2031
        12.2.1. E. coli
        12.2.2. Bacillus Megaterium
        12.2.3. Others
    12.3. Market Value Forecast, by Application, 2017–2031
        12.3.1. Production of Semisynthetic Penicillin
        12.3.2. Production of Semisynthetic Cephalosporin
        12.3.3. Others
    12.4. Market Value Forecast, by End-user, 2017–2031
        12.4.1. Pharmaceutical Companies
        12.4.2. Academic & Research Institutes
        12.4.3. Others
    12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        12.5.1. China
        12.5.2. Japan
        12.5.3. India
        12.5.4. Australia & New Zealand
        12.5.5. Rest of Asia Pacific
    12.6. Market Attractiveness Analysis
        12.6.1. By Source
        12.6.2. By Application
        12.6.3. By End-user
        12.6.4. By Country/Sub-region
13. Latin America Penicillin G Acylase Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast, by Source, 2017–2031
        13.2.1. E. coli
        13.2.2. Bacillus Megaterium
        13.2.3. Others
    13.3. Market Value Forecast, by Application, 2017–2031
        13.3.1. Production of Semisynthetic Penicillin
        13.3.2. Production of Semisynthetic Cephalosporin
        13.3.3. Others
    13.4. Market Value Forecast, by End-user, 2017–2031
        13.4.1. Pharmaceutical Companies
        13.4.2. Academic & Research Institutes
        13.4.3. Others
    13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        13.5.1. Brazil
        13.5.2. Mexico
        13.5.3. Rest of Latin America
    13.6. Market Attractiveness Analysis
        13.6.1. By Source
        13.6.2. By Application
        13.6.3. By End-user
        13.6.4. By Country/Sub-region
14. Middle East & Africa Penicillin G Acylase Market Analysis and Forecast
    14.1. Introduction
        14.1.1. Key Findings
    14.2. Market Value Forecast, by Source, 2017–2031
        14.2.1. E. coli
        14.2.2. Bacillus Megaterium
        14.2.3. Others
    14.3. Market Value Forecast, by Application, 2017–2031
        14.3.1. Production of Semisynthetic Penicillin
        14.3.2. Production of Semisynthetic Cephalosporin
        14.3.3. Others
    14.4. Market Value Forecast, by End-user, 2017–2031
        14.4.1. Pharmaceutical Companies
        14.4.2. Academic & Research Institutes
        14.4.3. Others
    14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        14.5.1. GCC Countries
        14.5.2. South Africa
        14.5.3. Rest of Middle East & South Africa
    14.6. Market Attractiveness Analysis
        14.6.1. By Source
        14.6.2. By Application
        14.6.3. By End-user
        14.6.4. By Country/Sub-region
15. Competition Landscape
    15.1. Market Player – Competition Matrix (by tier and size of companies)
    15.2. Company Profiles
        15.2.1. Merck KGaA (Sigma Aldrich)
            15.2.1.1. Company Overview
            15.2.1.2. Financial Overview
            15.2.1.3. Product Portfolio
            15.2.1.4. Business Strategies
            15.2.1.5. Recent Developments
        15.2.2. Fermenta Biotech Ltd.
            15.2.2.1. Company Overview
            15.2.2.2. Financial Overview
            15.2.2.3. Product Portfolio
            15.2.2.4. Business Strategies
            15.2.2.5. Recent Developments
        15.2.3. Biosynth
            15.2.3.1. Company Overview
            15.2.3.2. Financial Overview
            15.2.3.3. Product Portfolio
            15.2.3.4. Business Strategies
            15.2.3.5. Recent Developments
        15.2.4. Amicogen
            15.2.4.1. Company Overview
            15.2.4.2. Financial Overview
            15.2.4.3. Product Portfolio
            15.2.4.4. Business Strategies
            15.2.4.5. Recent Developments
        15.2.5. Creative Enzymes
            15.2.5.1. Company Overview
            15.2.5.2. Financial Overview
            15.2.5.3. Product Portfolio
            15.2.5.4. Business Strategies
            15.2.5.5. Recent Developments
        15.2.6. Crawford Wisdom International
            15.2.6.1. Company Overview
            15.2.6.2. Financial Overview
            15.2.6.3. Product Portfolio
            15.2.6.4. Business Strategies
            15.2.6.5. Recent Developments
        15.2.7. MuseChem Chemicals
            15.2.7.1. Company Overview
            15.2.7.2. Financial Overview
            15.2.7.3. Product Portfolio
            15.2.7.4. Business Strategies
            15.2.7.5. Recent Developments

List of Tables

Table 01: Global Penicillin G Acylases Market Value (US$ Mn) Forecast, by Source, 2017‒2031

Table 02: Global Penicillin G Acylases Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 03: Global Penicillin G Acylases Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 04: Global Penicillin G Acylases Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 05: North America Penicillin G Acylase Market Value (US$ Mn) Forecast, by Source, 2017‒2031

Table 06: North America Penicillin G Acylase Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 07: North America Penicillin G Acylase Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 08: North America Penicillin G Acylase Market Value (US$ Mn) Forecast, by Country, 2017‒2031

Table 09: Europe Penicillin G Acylase Market Value (US$ Mn) Forecast, by Source, 2017‒2031

Table 10: Europe Penicillin G Acylase Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 11: Europe Penicillin G Acylase Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 12: Europe Penicillin G Acylase Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017‒2031

Table 13: Asia Pacific Penicillin G Acylase Market Value (US$ Mn) Forecast, by Source, 2017‒2031

Table 14: Asia Pacific Penicillin G Acylase Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 15: Asia Pacific Penicillin G Acylase Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 16: Asia Pacific Penicillin G Acylase Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017‒2031

Table 17: Latin America Penicillin G Acylase Market Value (US$ Mn) Forecast, by Source, 2017‒2031

Table 18: Latin America Penicillin G Acylase Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 19: Latin America Penicillin G Acylase Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 20: Latin America Penicillin G Acylase Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017‒2031

Table 21: Middle East & Africa Penicillin G Acylase Market Value (US$ Mn) Forecast, by Source, 2017‒2031

Table 22: Middle East & Africa Penicillin G Acylase Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 23: Middle East & Africa Penicillin G Acylase Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 24: Middle East & Africa Penicillin G Acylase Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017‒2031

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ ペニシリンGアシラーゼの世界市場2023～2031：由来別、用途別(Penicillin G Acylase Market (Source: E. coli, Bacillus Megaterium, and Others; Application: Production of Semisynthetic Penicillin, Production of Semisynthetic Cephalosporin, and Others.) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 歯科用シリンジの世界市場2022～2031：製品別、材料別
  • 再利用型蘇生器の世界市場（2022～2031）：製品別、年齢層別
  • 世界の医療用サイクロトロン市場2023-2031：製品別（サイクロトロン10～12MeV、サイクロトロン16～24MeV、サイクロトロン24MeV以上）、用途別（診断、研究）

    • ◆H&Iグローバルリサーチのお客様（例）◆